Repare Therapeutics Inc. (RPTX)

Repare Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	72.83	84.72	111.27	159.52	334.43	326.18
Short-Term Investments	39.78	68.07	112.36	184.42	7.44	7.53
Cash & Short-Term Investments	112.6	152.79	223.63	343.94	341.87	333.71
Cash Growth	-37.24%	-31.68%	-34.98%	0.61%	2.44%	252.03%
Accounts Receivable	-	0.93	1.13	1.53	-	-
Other Receivables	8.29	11.42	14.18	2.8	3.23	6.16
Receivables	8.29	12.35	15.31	4.32	3.23	6.16
Prepaid Expenses	3.53	6.01	4.75	5.72	6.31	6.68
Total Current Assets	124.43	171.15	243.69	353.98	351.41	346.55
Property, Plant & Equipment	-	4.22	7.54	9.6	13.1	8.62
Long-Term Deferred Tax Assets	-	-	-	-	3.62	1.41
Other Long-Term Assets	0.6	1.14	2.67	0.5	0.59	0.5
Total Assets	126.75	176.51	253.9	364.08	368.72	357.09
Accounts Payable	1.33	3.62	2.4	0.46	2.3	2.25
Accrued Expenses	9.94	19.65	23.86	21.37	16.53	5.79
Current Portion of Leases	0.34	1.85	2.4	2.17	1.72	0.7
Current Income Taxes Payable	-	-	-	1.24	0.52	0.02
Current Unearned Revenue	-	-	10.22	53.1	11.92	2.07
Other Current Liabilities	-	0.17	0.19	0.27	2.1	0.18
Total Current Liabilities	11.62	25.29	39.08	78.62	35.09	11.01
Long-Term Leases	-	0.09	1.01	3.26	5.59	3.31
Long-Term Unearned Revenue	-	-	1.73	2.68	39.61	55.93
Total Liabilities	11.62	25.38	41.82	84.56	80.29	70.26
Common Stock	490.49	486.67	483.35	482.03	480.7	384.31
Additional Paid-In Capital	85.89	82.19	61.81	37.23	17.99	5.88
Retained Earnings	-461.33	-417.8	-333.11	-239.31	-210.27	-103.36
Comprehensive Income & Other	0.07	0.06	0.03	-0.43	-	-
Total Common Equity	115.13	151.13	212.08	279.52	288.42	286.83
Shareholders' Equity	115.13	151.13	212.08	279.52	288.42	286.83
Total Liabilities & Equity	126.75	176.51	253.9	364.08	368.72	357.09
Total Debt	0.34	1.93	3.41	5.43	7.31	4.01
Net Cash (Debt)	112.26	150.86	220.22	338.51	334.55	329.71
Net Cash Growth	-36.53%	-31.50%	-34.95%	1.18%	1.47%	251.75%
Net Cash Per Share	2.63	3.56	5.23	8.07	8.85	16.45
Filing Date Shares Outstanding	42.99	42.51	42.18	42.08	41.87	36.9
Total Common Shares Outstanding	42.99	42.51	42.18	42.04	41.85	36.9
Working Capital	112.81	145.86	204.61	275.36	316.33	335.54
Book Value Per Share	2.68	3.56	5.03	6.65	6.89	7.77
Tangible Book Value	115.13	151.13	212.08	279.52	288.42	286.83
Tangible Book Value Per Share	2.68	3.56	5.03	6.65	6.89	7.77
Machinery	-	8.95	8.97	7.06	6.51	5.24
Leasehold Improvements	-	2.55	2.55	2.52	2.47	0.71

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q